Updates on Pulmonary Neuroendocrine Carcinoids: Progress and Perspectives.

Area of Science:

• Oncology
• Pathology
• Molecular Biology

Background:

• Lung neuroendocrine neoplasms (NENs) encompass a spectrum from well-differentiated carcinoids to poorly differentiated carcinomas.
• Lung neuroendocrine tumors (LNETs) incidence is rising due to improved diagnostics and awareness.
• Existing World Health Organization (WHO) classifications have limitations in predicting pulmonary carcinoid behavior.

Purpose of the Study:

• To review the evolving landscape of LNETs, focusing on well-differentiated forms.
• To analyze current classification systems, clinicopathological features, and novel biomarkers.
• To explore potential for improved risk stratification and personalized therapies.

Main Methods:

• Literature review of current classification systems and clinicopathological features.
• Analysis of emerging prognostic and predictive biomarkers in LNETs.
• Exploration of molecular profiling data to identify distinct tumor subsets.

Main Results:

• Traditional criteria inadequately capture the biological complexity and clinical heterogeneity of LNETs.
• Advances in histopathology and molecular profiling are revealing distinct molecular subsets.
• Novel biomarkers show promise for improved risk stratification.

Conclusions:

• Current LNET classification requires enhancement to fully predict clinical behavior.
• Emerging biomarkers and molecular insights offer new avenues for personalized LNET management.
• Further research into LNET biology is crucial for developing targeted therapies.